Coastal Bridge Advisors, LLC
- SEC CIK
- 0001665976
- Latest filing
- Aug 17, 2026
URGN holding history
UroGen Pharma Ltd. in every 13F filed by Coastal Bridge Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
URGN overviewAll 13F holders of URGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 37,000
- Value
- $1.36M
- % of portfolio
- 0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 37,000 | $1.36M | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 37,000 | $665.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 37,000 | $866.5K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 37,000 | $738.1K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 37,000 | $506.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 37,000 | $409.2K | 0.1% | −2,000−5.1% | Reduced | Holders |
| Q4 2024 | 39,000 | $415.4K | 0.1% | −1,500−3.7% | Reduced | Holders |
| Q3 2024 | 40,500 | $514.4K | 0.1% | +2,000+5.2% | Added | Holders |
| Q2 2024 | 38,500 | $646.0K | 0.2% | +1,500+4.1% | Added | Holders |
| Q1 2024 | 37,000 | $555.0K | 0.1% | −750−2.0% | Reduced | Holders |
| Q4 2023 | 37,750 | $566.3K | 0.1% | −750−1.9% | Reduced | Holders |
| Q3 2023 | 38,500 | $539.4K | 0.1% | +768+2.0% | Added | Holders |
| Q2 2023 | 37,732 | $390.5K | 0.1% | +732+2.0% | Added | Holders |
| Q1 2023 | 37,000 | $341.9K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 37,000 | $328.2K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 37,000 | $308.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 37,000 | $303.0K | 0.1% | −1,000−2.6% | Reduced | Holders |
| Q1 2022 | 38,000 | $331.0K | 0.1% | −36,000−48.6% | Reduced | Holders |
| Q4 2021 | 74,000 | $1.02M | 0.2% | +37,000+100.0% | Added | Holders |
| Q3 2021 | 37,000 | $622.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 37,000 | $565.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 37,000 | $721.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.